<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>06955792741911</udiDi>
    <basicUdiDi>B-06955792741911</basicUdiDi>
    <tradeName>06955792741911</tradeName>
    <deviceName>Cortisol Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102060203</emdnCode>
    <emdnDescription>CORTISOL</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2135E-50</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:42.788Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741904</udiDi>
    <basicUdiDi>B-06955792741904</basicUdiDi>
    <tradeName>06955792741904</tradeName>
    <deviceName>Cortisol Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102060203</emdnCode>
    <emdnDescription>CORTISOL</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2135E-25</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:41.592Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741898</udiDi>
    <basicUdiDi>B-06955792741898</basicUdiDi>
    <tradeName>06955792741898</tradeName>
    <deviceName>Collagen Type Ⅲ N-peptide Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102060303</emdnCode>
    <emdnDescription>COLLAGEN TYPE III C-TERMINAL PROPEPTIDE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2134E-200</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:35.603Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741881</udiDi>
    <basicUdiDi>B-06955792741881</basicUdiDi>
    <tradeName>06955792741881</tradeName>
    <deviceName>Collagen Type Ⅲ N-peptide Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102060303</emdnCode>
    <emdnDescription>COLLAGEN TYPE III C-TERMINAL PROPEPTIDE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2134E-150</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:34.415Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741874</udiDi>
    <basicUdiDi>B-06955792741874</basicUdiDi>
    <tradeName>06955792741874</tradeName>
    <deviceName>Collagen Type Ⅲ N-peptide Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102060303</emdnCode>
    <emdnDescription>COLLAGEN TYPE III C-TERMINAL PROPEPTIDE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2134E-100</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:33.292Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741867</udiDi>
    <basicUdiDi>B-06955792741867</basicUdiDi>
    <tradeName>06955792741867</tradeName>
    <deviceName>Collagen Type Ⅲ N-peptide Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102060303</emdnCode>
    <emdnDescription>COLLAGEN TYPE III C-TERMINAL PROPEPTIDE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2134E-75</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:30.785Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741850</udiDi>
    <basicUdiDi>B-06955792741850</basicUdiDi>
    <tradeName>06955792741850</tradeName>
    <deviceName>Collagen Type Ⅲ N-peptide Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102060303</emdnCode>
    <emdnDescription>COLLAGEN TYPE III C-TERMINAL PROPEPTIDE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2134E-50</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:24.783Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741843</udiDi>
    <basicUdiDi>B-06955792741843</basicUdiDi>
    <tradeName>06955792741843</tradeName>
    <deviceName>Collagen Type Ⅲ N-peptide Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102060303</emdnCode>
    <emdnDescription>COLLAGEN TYPE III C-TERMINAL PROPEPTIDE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2134E-25</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:23.582Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741836</udiDi>
    <basicUdiDi>B-06955792741836</basicUdiDi>
    <tradeName>06955792741836</tradeName>
    <deviceName>Cancer Antigen 50 Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102030104</emdnCode>
    <emdnDescription>CANCER ANTIGEN 50</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2133E-200</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:22.380Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741829</udiDi>
    <basicUdiDi>B-06955792741829</basicUdiDi>
    <tradeName>06955792741829</tradeName>
    <deviceName>Cancer Antigen 50 Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102030104</emdnCode>
    <emdnDescription>CANCER ANTIGEN 50</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2133E-150</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:21.181Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741812</udiDi>
    <basicUdiDi>B-06955792741812</basicUdiDi>
    <tradeName>06955792741812</tradeName>
    <deviceName>Cancer Antigen 50 Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102030104</emdnCode>
    <emdnDescription>CANCER ANTIGEN 50</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2133E-100</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:15.319Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741805</udiDi>
    <basicUdiDi>B-06955792741805</basicUdiDi>
    <tradeName>06955792741805</tradeName>
    <deviceName>Cancer Antigen 50 Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102030104</emdnCode>
    <emdnDescription>CANCER ANTIGEN 50</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2133E-75</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:12.768Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741799</udiDi>
    <basicUdiDi>B-06955792741799</basicUdiDi>
    <tradeName>06955792741799</tradeName>
    <deviceName>Cancer Antigen 50 Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102030104</emdnCode>
    <emdnDescription>CANCER ANTIGEN 50</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2133E-50</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:11.560Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741782</udiDi>
    <basicUdiDi>B-06955792741782</basicUdiDi>
    <tradeName>06955792741782</tradeName>
    <deviceName>Cancer Antigen 50 Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102030104</emdnCode>
    <emdnDescription>CANCER ANTIGEN 50</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2133E-25</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:10.387Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741775</udiDi>
    <basicUdiDi>B-06955792741775</basicUdiDi>
    <tradeName>06955792741775</tradeName>
    <deviceName>Cancer Antigen 242 Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102030108</emdnCode>
    <emdnDescription>CANCER ANTIGEN 242</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2132E-200</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:04.353Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741768</udiDi>
    <basicUdiDi>B-06955792741768</basicUdiDi>
    <tradeName>06955792741768</tradeName>
    <deviceName>Cancer Antigen 242 Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102030108</emdnCode>
    <emdnDescription>CANCER ANTIGEN 242</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2132E-150</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:03.744Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741751</udiDi>
    <basicUdiDi>B-06955792741751</basicUdiDi>
    <tradeName>06955792741751</tradeName>
    <deviceName>Cancer Antigen 242 Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102030108</emdnCode>
    <emdnDescription>CANCER ANTIGEN 242</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2132E-100</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:01.962Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741744</udiDi>
    <basicUdiDi>B-06955792741744</basicUdiDi>
    <tradeName>06955792741744</tradeName>
    <deviceName>Cancer Antigen 242 Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102030108</emdnCode>
    <emdnDescription>CANCER ANTIGEN 242</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2132E-75</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:10:00.753Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741737</udiDi>
    <basicUdiDi>B-06955792741737</basicUdiDi>
    <tradeName>06955792741737</tradeName>
    <deviceName>Cancer Antigen 242 Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102030108</emdnCode>
    <emdnDescription>CANCER ANTIGEN 242</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2132E-50</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:09:54.861Z</lastUpdated>
  </row>
  <row>
    <udiDi>06955792741720</udiDi>
    <basicUdiDi>B-06955792741720</basicUdiDi>
    <tradeName>06955792741720</tradeName>
    <deviceName>Cancer Antigen 242 Chemiluminescence Immunoassay Kit</deviceName>
    <manufacturerName>Sansure Biotech Inc.</manufacturerName>
    <manufacturerSrn>CN-MF-000011392</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102030108</emdnCode>
    <emdnDescription>CANCER ANTIGEN 242</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S2132E-25</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-28T18:09:52.377Z</lastUpdated>
  </row>
</eudamedExport>